Loading...
The association between cardiovascular morbidity and obstructive sleep apnea syndrome (OSAS) is widely recognized. The effect of treatment with continuous positive airway pressure (CPAP) on blood pressure, a potential mediator of cardiovascular events, has not been fully delineated. In a meta-analysis of 12 placebo-controlled randomized trials involving 572 patients, researchers assessed whether CPAP treatment reduces 24-hour ambulatory mean blood pressure (MBP). The proportion of patients who were hypertensive ranged from 0% to 100%. Study duration ranged from 1 to 12 weeks.
In all studies, 24-hour MBP decreased in the CPAP groups compared with the placebo groups, with relative decreases ranging from 0.30 to 10.50 mm Hg. Pooled results show…